The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
The DOI matches its Crossref record; 218 of the 220 references it cites were found in a registry or an index.
Abstract
Beside the well-known deficiency in serotonergic neurotransmission as pathophysiological correlate of major depression (MD), recent evidence points to a pivotal role of increased glutamate receptor activation as well. However, cause and interaction of these neurotransmitter alterations are not understood. In this review, we present a hypothesis integrating current concepts of neurotransmission and hypothalamus-pituitary-adrenal (HPA) axis dysregulation with findings on immunological alterations and alterations in brain morphology in MD. An immune activation including increased production of proinflammatory cytokines has repeatedly been described in MD. Proinflammatory cytokines such as interleukin-2, interferon-gamma, or tumor necrosis factor-alpha activate the tryptophan- and serotonin-degrading enzyme indoleamine 2,3-dioxygenase (IDO). Depressive states during inflammatory somatic disorders are also associated with increased proinflammatory cytokines and increased consumption of tryptophan via activation of IDO. An enhanced consumption of serotonin and its precursor tryptophan through IDO activation could well explain the reduced availability of serotonergic neurotransmission in MD. An increased activation of IDO and its subsequent enzyme kynurenine monooxygenase by proinflammatory cytokines, moreover, leads to an enhanced production of quinolinic acid, a strong agonist of the glutamatergic N-methyl-D-aspartate receptor. In inflammatory states of the central nervous system, IDO is mainly activated in microglial cells, which preferentially metabolize tryptophan to the NMDA receptor agonist quinolinic acid, whereas astrocytes - counteracting this metabolism due to the lack of an enzyme of this metabolism - have been observed to be reduced in MD. Therefore the type 1/type 2 immune response imbalance, associated with an astrocyte/microglia imbalance, leads to serotonergic deficiency and glutamatergic overproduction. Astrocytes are further strongly involved in re-uptake and metabolic conversion of glutamate. The reduced number of astrocytes could contribute to both, a diminished counterregulation of IDO activity in microglia and an altered glutamatergic neurotransmission. Further search for antidepressant agents should take into account anti-inflammatory drugs, for example, cyclooxygenase-2 inhibitors, might exert antidepressant effects by acting on serotonergic deficiency, glutamatergic hyperfunction and antagonizing neurotoxic effects of quinolinic acid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An alternative explanation for the involvement of IDO in the pathophysiology of depression-like behaviour is that degradation of tryptophan along the kynurenine pathway generates compounds that act as either agonists (for example, quinolinic acid and 3 hydroxy-kynurenine) or antagonists (for example, kynurenic acid) of the NMDA (N-methyl-D-aspartate) receptor (BOX 1).”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [61]
In the citing paper
“cytokine-induced activation of the enzyme, indolamine 2,3 dioxygenase (IDO), which metabolizes tryptophan to kynurenine and quinolinic acid, is believed to contribute to reduced availability of serotonin.16,23,24”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [23]
In the citing paper
“one hypothesis postulates that proinflammatory cytokines stimulate indoleamine 2,3-dioxygenase (IDO) in glial cells to convert tryptophan to kynurenine which is transformed into the neurotoxic quinolinic acid inside the brain (Müller and Schwarz, 2007;Walker et al., 2014).”
From A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder (2014) · cites this paper as Müller and Schwarz, 2007
In the citing paper
“kynurenic acid is an N-methyl d-aspartate (NMDA) receptor antagonist, and is generally considered neuroprotective”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Müller and Schwarz, 2007
Citations
Cites
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Rates and risk of postpartum depression – a meta-analysis
O'hara, M. W., & Swain, A. M. (1996) · International Review of Psychiatry · doi:10.3109/09540269609037816 · Cited by 3,116
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Davis, H. S. (1966) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1966.03100200106038 · Cited by 1,719
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Research works printed but not linked: 5
- Matussek N . Neurobiologie und depression. Med Monatsschr 1966; 3: 109–112.
- Abou-Saleh MT, Ghubash R, Karim L, Krymski M, Anderson DN . The role of pterins and related factors in the biology of early postpartum depression. Eur Neuropsychopharmacol 1999; 9: 295–300.
- Rajkowska G . Astroglia in the cortex of schizophrenics: histopathology finding. World J Biol Psychiatry 2005; 6: 74.
- Thomas K . Immunomodulation in Mice Induced by the Antidepressant Drug Zimeldine. Thesis, University of Utrecht: Utrecht, 1989.
- Song C, Leonard BE . An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med Sci Res 1994; 22: 313–314.
Cited by
Items 201–300 of 681
Retinal correlates of psychiatric disorders
Almonte, M. T., Capellàn, P., Yap, T. E., & Cordeiro, M. F. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320905215 · Cited by 68
Liao, L., Zhang, X. D., Li, J., Zhang, Z. W., Yang, C., Rao, C., Zhou, C., Zeng, L., Zhao, L., Fang, L., et al. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.036 · Cited by 66
Neuronal Mitochondrial Dysfunction and Bioenergetic Failure in Inflammation-Associated Depression
Casaril, A. M., Dantzer, R., & Orth, C. B. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.725547 · Cited by 71
Altalib, H. H., & Kanner, A. M. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.10.009 · Cited by 68
Schrepf, A., Lutgendorf, S. K., & Pyter, L. M. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.04.010 · Cited by 66
Becking, K., Haarman, B. C. M., Grosse, L., Nolen, W. A., Claes, S., Arolt, V., Schoevers, R. A., & Drexhage, H. A. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.004 · Cited by 61
da Cunha, L. L., Feter, N., Alt, R., & Rombaldi, A. J. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.086 · Cited by 72
Novío, S., Núñez, M. J., Amigo, G., & Freire-Garabal, M. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00736.x · Cited by 60
IL-4/10 prevents stress vulnerability following imipramine discontinuation
Han, A., Yeo, H., Park, M.-J., Kim, S. H., Choi, H. J., Hong, C.-W., & Kwon, M.-S. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0416-3 · Cited by 60
Depression, cytokines and experimental pain: Evidence for sex-related association patterns
Euteneuer, F., Schwarz, M., Hennings, A., Riemer, S., Stapf, T. M., Selberdinger, V. B., & Rief, W. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.11.017 · Cited by 64
Self-citationRodríguez-Muñoz, M., Cortés‐Montero, E., Pozo-Rodrigálvarez, A., Sánchez‐Blázquez, P., & Garzón-Niño, J. (2015) · Oncotarget · doi:10.18632/oncotarget.6064 · Cited by 68
Al-Askar, M., Bhat, R. S., Selim, M. E., AL-Ayadhi, L. Y., & El-Ansary, A. K. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1763-7 · Cited by 61
Inflammation in neurological and psychiatric diseases
Khansari, P. S., & Sperlágh, B. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0124-x · Cited by 66
Moretti, M., Budni, J., Freitas, A. E., Neis, V. B., Ribeiro, C. M., Balen, G. O., Rieger, D. K., Leal, R. B., & Rodrigues, A. L. S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.006 · Cited by 58
How lipids may affect risk for suicidal behavior
Daray, F. M., Mann, J. J., & Sublette, M. E. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.06.007 · Cited by 54
Yin, W., Mei, L., Sun, T., Wang, Y., Li, J., Chen, C., Farzinpour, Z., Mao, Y., Tao, W., Li, J., et al. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003133 · Cited by 60
Amino Acid Metabolism in Rheumatoid Arthritis: Friend or Foe?
Panfili, E., Gerli, R., Grohmann, U., & Pallotta, M. T. (2020) · Biomolecules · doi:10.3390/biom10091280 · Cited by 60
Maxeiner, H. G., Rojewski, M., Schmitt, A., Tumani, H., Bechter, K., & Schmitt, M. W. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.08.003 · Cited by 66
Inflammatory Biomarkers in 70 Depressed Inpatients With and Without the Metabolic Syndrome
Zeugmann, S., Quante, A., Heuser, I., Schwarzer, R., & Anghelescu, I. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04767blu · Cited by 57
A biological basis for depression in pancreatic cancer
Botwinick, I. C., Pursell, L., Yu, G., Cooper, T., Mann, J. J., & Chabot, J. A. (2014) · HPB · doi:10.1111/hpb.12201 · Cited by 55
Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats
Wang, Y., Yang, F., Liu, Y.-F., Gao, F., & Jiang, W. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.035 · Cited by 56
Pancreatic Cancer–Associated Depression: A Case Report and Review of the Literature
Barnes, A., Yeo, T., Leiby, B., Kay, A., & Winter, J. (2018) · Pancreas · doi:10.1097/mpa.0000000000001148 · Cited by 43
Immunotherapy for depression: Recent insights and future targets
Bai, Y., Cai, Y., Chang, D., Li, D., Huo, X., & Zhu, T. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108624 · Cited by 58
Clinical Characteristics of Diabetes Mellitus and Suicide Risk
Conti, C. M., Chiara, M., Francesco, G. D., Fraticelli, F., Vitacolonna, E., & Fulcheri, M. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00040 · Cited by 68
de Oliveira, F. R., Fantucci, M. Z., Adriano, L., Valim, V., Cunha, T. M., Louzada‐Júnior, P., & Rocha, E. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123953 · Cited by 60
Aronica, R., Enrico, P., Squarcina, L., Brambilla, P., & Delvecchio, G. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104922 · Cited by 58
Li, B., Zhang, S., Zhang, H., Hertz, L., & Peng, L. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100094 · Cited by 54
Iseme, R. A., McEvoy, M., Kelly, B. J., Agnew, L. L., Attia, J. R., & Walker, F. R. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.008 · Cited by 57
Neuroimmune endocrine effects of antidepressants
Carvalho, L. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s16409 · Cited by 53
Zhu, X., Jing, L., Chen, C., Shao, M., Fan, Q., Diao, J., Liu, Y., Lv, Z., & Sun, X. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.11.031 · Cited by 53
Lin, P., Li, D., Shi, Y., Li, Q., Guo, X., Dong, K., Chen, Q., Lou, X., Li, Z., Li, P., et al. (2021) · Nutrients · doi:10.3390/nu15071752 · Cited by 58
Kynurenine pathway and white matter microstructure in bipolar disorder
Poletti, S., Myint, A.-M., Schütze, G. A., Bollettini, I., Mazza, E. B., Grillitsch, D., Locatelli, C., Schwarz, M., Colombo, C., & Benedetti, F. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0731-4 · Cited by 52
Self-citationGlutamate-based depression GBD
McCarthy, D. J., Alexander, R., Smith, M. A., Pathak, S., Kanes, S., Lee, C., & Sanacora, G. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.02.009 · Cited by 54
Exercise-induced release of cytokines in patients with major depressive disorder
Hallberg, L., Janelidze, S., Engström, G., Wisén, A. G. M., Westrin, Å., & Brundin, L. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.133 · Cited by 56
Husain, M. I., Ledwos, N., Fellows, E., Baer, J., Rosenblat, J. D., Blumberger, D. M., Mulsant, B. H., & Castle, D. J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1076459 · Cited by 50
Bupropion pre-treatment of endotoxin-induced depressive symptoms
DellaGioia, N., Devine, L., Pittman, B. P., & Hannestad, J. O. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.10.008 · Cited by 51
Deng, Z.-F., Zheng, H.-L., Chen, J.-G., Luo, Y., Xu, J.-F., Zhao, G., Lu, J.-J., Li, H.-H., Gao, S.-Q., Zhang, D.-Z., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhy047 · Cited by 48
The dose makes the poison: From glutamate-mediated neurogenesis to neuronal atrophy and depression
Rubio-Casillas, A., & Fernández-Guasti, A. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0066 · Cited by 49
“Accumulating evidence suggests that excessive glutamatergic neurotransmission could be involved in the etiology of depression (Sanacora et al., 2004, 2012; Müller and Schwarz, 2007; Grimm et al., 2012; Popoli et al., 2012; Deutschenbaur et al., 2016).”
BackgroundInfluentialNorden, D. M., Devine, R., Bicer, S., Jing, R., Reiser, P. J., Wold, L. E., Godbout, J. P., & McCarthy, D. O. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.12.045 · Cited by 48
da Silva, L. E. M., de Santana, M. L. P., Costa, P. R. D. F., Pereira, E. M., Nepomuceno, C. M. M., Queiroz, V. A. D. O., de Oliveira, L. P. M., da Conceição‐Machado, M. E. P., & de Sena, E. P. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa039 · Cited by 61
Basic Aspects of the Immunology of Neuroinflammation
Wohleb, E. S., & Godbout, J. P. (2013) · Modern trends in psychiatry · doi:10.1159/000343964 · Cited by 60
Astroglia in the Vulnerability to and Maintenance of Stress-Mediated Neuropathology and Depression
Miguel-Hidalgo, J. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.869779 · Cited by 56
Kranaster, L., Hoyer, C., Aksay, S. S., Bumb, J. M., Müller, N., Zill, P., Schwarz, M., & Sartorius, A. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1355473 · Cited by 52
Self-citationPryce, C. R., & Seifritz, E. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.05.003 · Cited by 52
Dalton, V. S., Verdurand, M., Walker, A., Hodgson, D. M., & Zavitsanou, K. (2012) · ISRN Psychiatry · doi:10.5402/2012/451865 · Cited by 43
Pawłowski, T., Radkowski, M., Małyszczak, K., Inglot, M., Zalewska, M., Jabłońska, J., & Laskus, T. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.03.004 · Cited by 51
Grygiel‐Górniak, B., Limphaibool, N., & Puszczewicz, M. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12826 · Cited by 50
Disgust affects TNF-α, IL-6 and noradrenalin levels in patients with obsessive–compulsive disorder
Fluitman, S. B. A. H. A., Denys, D. A. J. P., Heijnen, C. J., & Westenberg, H. G. M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.12.005 · Cited by 49
Effects of Interleukin-6 on Depression Risk in Dialysis Patients
Sonikian, M. A., Metaxaki, P., Papavasileiou, D., Boufidou, F., Nikolaou, C. C., Vlassopoulos, D., & Vlahakos, D. (2010) · American Journal of Nephrology · doi:10.1159/000285110 · Cited by 54
Krause, D., Myint, A.-M., Schuett, C., Musil, R., Dehning, S., Cerovecki, A., Riedel, M. J., Arolt, V., Schwarz, M., & Müller, N. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00016 · Cited by 46
Self-citationStapelberg, N. J. C., Pratt, R., Neumann, D. L., Shum, D., Brandis, S. J., Muthukkumarasamy, V., Stantić, B., Blumenstein, M., & Headrick, J. P. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.005 · Cited by 45
Edgar, N. M., Touma, C., Palme, R., & Sibille, E. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.40 · Cited by 40
Hage, Z., Madeira, M. M., Koliatsis, D., & Tsirka, S. E. (2024) · BMC Immunology · doi:10.1186/s12865-024-00653-9 · Cited by 50
Voluntary exercise and depression-like behavior in rodents: are we running in the right direction?
Mul, J. D. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0165 · Cited by 47
Nichols, C. D. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/475108 · Cited by 49
Current Neurological Observations and Complications of Dengue Virus Infection
Solbrig, M. V., & Perng, G. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0550-4 · Cited by 42
Lotrich, F. E., Ferrell, R. E., Rabinovitz, M., & Pollock, B. G. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181de8966 · Cited by 41
Taraz, M., Khatami, M., Gharekhani, A., Abdollahi, A., Khalili, H., & Dashti‐Khavidaki, S. (2012) · European Cytokine Network · doi:10.1684/ecn.2013.0326 · Cited by 44
A new perspective on depression and neuroinflammation: Non-coding RNA
Zhou, S., Chen, R., She, Y., Liu, X., Zhao, H., Li, C., & Jia, Y. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.02.007 · Cited by 45
Fluitman, S. B. A. H. A., Denys, D. A. J. P., Vulink, N. C. C., Schutters, S. I. J., Heijnen, C. J., & Westenberg, H. G. M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.05.008 · Cited by 47
Impact of lithium alone and in combination with antidepressants on cytokine production in vitro
Petersein, C., Sack, U., Mergl, R., Schönherr, J., Schmidt, F. M., Lichtblau, N., Kirkby, K. C., Bauer, K., & Himmerich, H. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1328-6 · Cited by 40
Integrating the monoamine and cytokine hypotheses of depression: Is histamine the missing link?
Hersey, M., Hashemi, P., & Reagan, L. P. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15392 · Cited by 46
Neurological and Neurobehavioral Disorders Associated with Toxoplasma gondii Infection in Humans
Virus, M. A., Ehrhorn, E. G., Lui, L. M., & Davis, P. H. (2021) · Journal of Parasitology Research · doi:10.1155/2021/6634807 · Cited by 45
Chronic pain causes a persistent anxiety state leading to increased ethanol intake in CD1 mice
González-Sepúlveda, M., Pozo, O. J., Marcos, J., & Valverde, O. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115622238 · Cited by 40
“Moreover, cytokine IL-6 also enhances synthesis of quinolinic acid, a kynurenine neurotoxic metabolite in the brain of some depressed patients acting as an agonist of the glutamate NMDA receptor (Müller et al., 2007; Myint et al., 2012).”
BackgroundResultZhou, T., Sun, J., Tang, L.-D., Yuan, Y., Wang, J., & Zhang, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1007624 · Cited by 47
Chen, J.-J., Wang, T., An, C.-D., Jiang, C., Zhao, J., & Li, S. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0017 · Cited by 42
Baldwin, D. S., Hou, R. H., Gordon, R., Huneke, N. T. M., & Garner, M. J. (2017) · CNS Drugs · doi:10.1007/s40263-017-0423-2 · Cited by 41
Chan, S. Y., Probert, F., Radford‐Smith, D. E., Hebert, J. C., Claridge, T. D. W., Anthony, D. C., & Burnet, P. W. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-74008-w · Cited by 42
Li, W., Chen, M., Feng, X., Song, M., Shao, M., Yang, Y., Zhang, L., Liu, Q., Lv, L., & Su, X. (2021) · Brain and Behavior · doi:10.1002/brb3.2133 · Cited by 45
Varghese, S. M., Patel, S., Nandan, A., Jose, A., Ghosh, S., Sah, R. K., Menon, B., Athira, K. V., & Chakravarty, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04205-5 · Cited by 41
Mindt, S., Neumaier, M., Hoyer, C., Sartorius, A., & Kranaster, L. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1618494 · Cited by 42
Ion Channel Dysfunction and Neuroinflammation in Migraine and Depression
Eren‐Koçak, E., & Dalkara, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.777607 · Cited by 42
Ferencová, N., Višňovcová, Z., Ondrejka, I., Funakova, D., Hrtánek, I., Kelčíková, S., & Tonhajzerová, I. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s387588 · Cited by 41
Bitsika, V., Sharpley, C. F., & Peters, K. (2010) · Bond University Research Portal (Bond University) · Cited by 73
Neuro-immune interactions across development: A look at glutamate in the prefrontal cortex
Macht, V. A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.039 · Cited by 41
Poletti, S., Melloni, E. M. T., Aggio, V., Colombo, C., Valtorta, F., Benedetti, F., & Comai, S. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.08.034 · Cited by 42
Kim, S. Y., Min, C., Oh, D. J., & Choi, H. G. (2019) · Rheumatology · doi:10.1093/rheumatology/kez559 · Cited by 41
Lovastatin potentiates the antidepressant efficacy of fluoxetine in rats
Renshaw, P. F., Parsegian, A., Yang, C. K., Novero, A., Yoon, S. J., Lyoo, I. K., Cohen, B. M., & Carlezon, W. A. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.10.017 · Cited by 39
Cassol, E., Misra, V., Morgello, S., Kirk, G., Mehta, S., & Gabuzda, D. (2015) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000551 · Cited by 39
de Boer, J. N., Vingerhoets, C., Hirdes, M., McAlonan, G. M., Amelsvoort, T. V., & Zinkstok, J. R. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.06.020 · Cited by 38
Peptide OM-LV20 protects astrocytes against oxidative stress via the ‘PAC1R/JNK/TPH1’ axis
Yin, S., Pang, A., Liu, C., Li, Y., Liu, N., Li, S., Li, C., Sun, H., Fu, Z., Wang, Y., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102429 · Cited by 37
Obesity and Bipolar Disorder: Synergistic Neurotoxic Effects?
Liu, C. S., Carvalho, A. F., Mansur, R. B., & McIntyre, R. S. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0067-7 · Cited by 42
Hayes, J. F., Khandaker, G. M., Anderson, J., Mackay, D., Zammit, S., Lewis, G., Smith, D. J., & Osborn, D. P. J. (2017) · Psychological Medicine · doi:10.1017/s0033291716001574 · Cited by 37
Basic Concept of Microglia Biology and Neuroinflammation in Relation to Psychiatry
Mattei, D., & Notter, T. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_83 · Cited by 39
The inflammatory hypothesis of mood spectrum broadened to fibromyalgia and chronic fatigue syndrome.
Dell’Osso, L., Bazzichi, L. M., Baroni, S., Falaschi, V., Conversano, C., Carmassi, C., & Marazziti, D. (2015) · PubMed · Cited by 46
Müller, N., & Bechter, K. (2013) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2013.04.004 · Cited by 37
Self-citationDepressão, antidepressivos e sistema imune: um novo olhar sobre um velho problema
Vismari, L., Alves, G. J., & Palermo‐Neto, J. (2008) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832008000500004 · Cited by 77
Traks, T., Koido, K., Eller, T., Maron, E., Kingo, K., Vasar, V., Vasar, E., & Kõks, S. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-111 · Cited by 40
Raison, C. L. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_26 · Cited by 36
Singhal, G., Morgan, J., Jawahar, M. C., Corrigan, F., Jaehne, E. J., Toben, C. G., Breen, J., Pederson, S., Manavis, J., Hannan, A. J., et al. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112501 · Cited by 43
Stapelberg, N. J. C., Neumann, D. L., Shum, D., & Headrick, J. P. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.10.014 · Cited by 37
Eskelund, A., Budac, D. P., Sánchez, C., Elfving, B., & Wegener, G. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.024 · Cited by 35
Kranaster, L., Hoyer, C., Aksay, S. S., Bumb, J. M., Müller, N., Zill, P., Schwarz, M., Moll, N., Lutz, B., Bîndilă, L., et al. (2018) · Neuropsychobiology · doi:10.1159/000491401 · Cited by 37
Self-citationHerrstedt, A., Bay, M. L., Simonsen, C., Sundberg, A., Egeland, C., Thorsen-Streit, S., Djurhuus, S. S., Ueland, P. M., Midttun, Ø., Pedersen, B. K., et al. (2019) · Acta Oncologica · doi:10.1080/0284186x.2018.1558371 · Cited by 36
Basal myokine levels are associated with quality of life and depressed mood in older adults
Mucher, P., Batmyagmar, D., Perkmann, T., Repl, M., Radakovics, A., Ponocny‐Seliger, E., Lukas, I., Fritzer‐Szekeres, M., Lehrner, J. P., Knogler, T., et al. (2021) · Psychophysiology · doi:10.1111/psyp.13799 · Cited by 36
Lee, J. J., Piras, E., Tamburini, S., Bu, K., Wallach, D. S., Remsen, B., Cantor, A., Kong, J., Goetz, D. M., Hoffman, K. W., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115279 · Cited by 37
Miguel-Hidalgo, J. J., Overholser, J. C., Jurjus, G. J., Meltzer, H. Y., Dieter, L., Konick, L., Stockmeier, C. A., & Rajkowska, G. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.052 · Cited by 32
Lebeña, A., Vegas, Ó., Gómez-Lázaro, E., Arregi, A., Garmendia, L., Beitia, G., & Azpiroz, A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.045 · Cited by 34
Kobayashi-Gutiérrez, A., Martínez-Bonilla, G., Bernard‐Medina, A. G., Troyo‐Sanromán, R., González-Díaz, V., Castro-Contreras, E., Vázquez-Valls, E., & Torres-Mendoza, B. M. (2008) · Rheumatology International · doi:10.1007/s00296-008-0834-y · Cited by 37
A neurotransmitter system that regulates macrophage pro-inflammatory functions
Reyes-García, M. G., & García-Tamayo, F. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.06.024 · Cited by 36
Metadata
- Authors
- Müller, N., & Schwarz, M. J.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Venue
- Molecular Psychiatry
- Published
- 2007-04-24
- Volume
- 12
- Issue
- 11
- Pages
- 988-1000
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2002250647
- Cited by
- 670
- References
- 220
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 30 · 2023: 31 · 2022: 48 · 2021: 41 · 2020: 37 · 2019: 34 · 2018: 42 · 2017: 25 · 2016: 49 · 2015: 34 · 2014: 39 · 2013: 32 · 2012: 33
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, serotonin, glutamate, indoleamine 2,3-dioxygenase, kynurenine pathway, quinolinic acid, NMDA receptor, inflammatory cytokines, microglia, astrocytes, tryptophan metabolism, hypothalamic-pituitary-adrenal axis, immune activation, antidepressants, COX-2 inhibitors
- MeSH terms
- Animals, Depression, Humans, Hypothalamo-Hypophyseal System, Immune System, Pituitary-Adrenal System, Serotonin, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.